Low-Protein Infant Formula Reducing Metabolic Syndrome Risk
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Infant formulas with high protein content contribute to increased risk of obesity, metabolic syndrome, and insulin resistance in infants, particularly those born to non-obese and non-overweight mothers, and cause damage to non-mature organs due to excessive protein burden.
Innovation Solution
A nutritional composition with a protein content of less than 1.8 g/100 kcal, comprising a protein source, lipid source, and carbohydrate source, designed to reduce the risk of metabolic syndrome, obesity, and insulin resistance, while promoting a growth rate and hormonal profile similar to breastfed infants, and minimizing protein burden on non-mature organs.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If infant formula has high protein content, then growth rate is improved, but risk of obesity and metabolic syndrome increases
Solution Approach 1:
The patent applies parameter changes by precisely controlling the protein content to be less than 1.8 g/100 kcal, which is lower than conventional infant formulas. This parameter adjustment resolves the contradiction by reducing the harmful metabolic effects while maintaining adequate growth through optimized nutrient composition and balance.
Solution Approach 2:
The patent applies local quality by optimizing the specific amino acid profile and protein distribution within the formula. Rather than simply reducing total protein, the invention focuses on the quality and composition of proteins, ensuring essential amino acids are present in appropriate amounts while keeping total protein content low to prevent obesity and metabolic syndrome.
2Weight of moving object
If infant formula has high protein content, then weight gain is improved, but protein burden on non-mature organs increases
Solution Approach 1:
The patent applies parameter changes by setting the protein content threshold at less than 1.8 g/100 kcal, which reduces the protein burden on immature renal and hepatic organs in infants. This parameter optimization allows adequate weight gain while protecting developing organ systems from excessive protein stress.
3Object-affected harmful factors
If infant formula protein content is reduced, then risk of obesity is decreased, but growth rate may be insufficient
Solution Approach 1:
The patent applies composite materials by combining multiple nutrient components in a balanced formulation. The low-protein formula is complemented by optimized carbohydrates, fats, vitamins, and minerals to ensure adequate energy and nutritional support for growth, thereby maintaining growth rate while reducing obesity risk.
Solution Approach 2:
The patent applies local quality by enhancing the quality of individual nutrients to compensate for reduced protein content. The formula includes optimized amino acid profiles, essential fatty acids, and micronutrients that support growth and development without requiring high total protein levels.
Data Source
AI summary
The present invention relates to the use of a nutritional composition having a low amount of protein, such as less than 1.8 g/100 kcal for administration to infants of non-obese and non-overweight mothers so as to reduce the risk of developing metabolic syndrome, increased weight gain, increased fat deposition, overweight, obesity, insulin resistance, glucose intolerance or diabetes mellitus later in said infant's life.